The investment banking advisory firm has strengthened in Singapore as secondaries activity gathers pace across the region; Hart previously worked at Adams Street Partners.

Amid a structural shift towards Asia, Insilico Medicine's IPO in December was a significant moment for the exchange, while French biotech TheraVectys is understood to be considering a listing.

SC's operating profit grew 6% last year; Zurich Australia snaps up life insurer ClearView; Citi Vietnam appoints Thai Nguyet Minh as head of markets.

Co-investors in the take-private deal for the healthcare firm include 65 Equity Partners, the Employees Provident Fund and China’s Silk Road Fund.

Industrial activity remained a “consistent bright spot" throughout 2025 amid 5% GDP growth; there are consistent deflationary pressures.

If the deal is finalised, a combination of the US and UK global asset managers will control almost $2.5 trillion of assets under management; they both have offices across Apac.

Jalal Almarhoon previously worked for BNP Paribas in Saudi Arabia.

Hong Kong-based Peng Yu is a specialist in private equity and M&A transactions.

Sherlyn Lau has joined with a team of 12 in Hong Kong to lead the law firm's Apac capital markets and corporate finance team.